Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call Transcript
seekingalpha.com·1d
Flag this post

Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call November 3, 2025 8:00 AM EST

Company Participants

Darren Opland - Director of Corporate Communications Herriot Tabuteau - Founder, Chairman, CEO & President Nick Pizzie - Chief Financial Officer Ari Maizel - Chief Commercial Officer Mark Jacobson - Chief Operating Officer

Conference Call Participants

Leonid Timashev - RBC Capital Markets, Research Division Basma Radwan Ibrahim - Leerink Partners LLC, Research Division Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division Sean Laaman - Morgan Stanley, Research Division Ashwani Verma - UBS Investment Bank, Research…

Similar Posts

Loading similar posts...